Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

Blood cancer patients are more vulnerable to the effects of COVID-19, study finds

A newly published study led by the Universities of Oxford and Birmingham has found that, compared to other cancers, patients with blood cancers are more vulnerable to the effects of the coronavirus pandemic.